MedPath

Treating Jaw Cysts Can These Treatments Reduce Recurrence

Phase 2
Conditions
Health Condition 1: K090- Developmental odontogenic cysts
Registration Number
CTRI/2024/07/071123
Lead Sponsor
Goverment Dental College Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients who diagnosed with odontogenic keratocyst (biopsy proven)

2.Patients diagnosed with syndromic multiple OKC

3.Patient willing for surgical enucleation followed by local chemical curettage or cryotherapy

4.Patients under ASA I / ASA II category

Exclusion Criteria

1.Recurrent OKC cases

2.Patients not willing for surgical enucleation

3.Medically compromised patients

4.ASA III And ASA IV

5.Pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the Recurrence of odontogenic keratocyst after treatment using 5 flurouracil and liquid nitrogen after surgical enucleation. <br/ ><br>Timepoint: 6th Month
Secondary Outcome Measures
NameTimeMethod
1.To compare the post-operative nerve paraesthesia in odontogenic keratocyst after treatment using 5 flurouracil and liquid nitrogen after surgical enucleation. <br/ ><br>2.To compare the post-operative wound healing in odontogenic keratocyst after treatment using 5 flurouracil and liquid nitrogen after surgical enucleation.Timepoint: 3rd day, 7th day, 6th Month
© Copyright 2025. All Rights Reserved by MedPath